As a leader who has committed much of his career to improving healthcare — an industry that holds millions of people’s lives ...

Like many insurers, UnitedHealthcare and Optum are dealing with a surge in digital solutions, according to Dr. Debra Nussbaum, senior director of behavioral health at Optum. And they’re trying ...

In a recent interview, Elizabeth Mitchell, president and CEO of the Purchaser Business Group on Health, discussed employers' ...

Former President Donald Trump’s return to the White House is certain to bring about changes across many facets of the healthcare sector — including reproductive care, federal insurance ...

Maternal mental health conditions are among the most prevalent complications during pregnancy and the postpartum period. There is also a significant economic burden associated with maternal mental ...

When Johnson & Johnson backed down from its proposal to modify the way it supplies certain drugs under the 340B statute, it hinted litigation could be its next step to effect changes that address ...

Fort Health, an integrated behavioral health company, has secured $5.5 million, it announced Tuesday. It will use these funds to bring mental health services into more pediatricians’ offices in ...

There is no single remedy to fix extreme healthcare cost challenges. Healthcare inflation cuts across multiple factors. So employers need multiple ways to reverse these trends in 2025. Join us for ...

Tech giant Microsoft has pursued dozens of partnerships with health systems over the past few years, with these focusing mainly on fine-tuning AI models to better serve busy clinicians. Last month ...

From L-R: Betty Pio, partner at Kearney; Dr. Rekha Kumar, chief medical officer at Found and practicing endocrinologist at New York-Presbyterian; Sheila Shah, managing director, L.E.K. Consulting ...

Since being launched in 2022, crisis counselors working for the 988 Suicide & Crisis Lifeline have answered more than 10 million calls. The hotline provides free, confidential support for people ...

GLP-1 is expected to grow to a $71 billion industry by 2031. GLP-1 medications are fueled by the 66% of Americans who are classified as overweight or obese. No matter what metric, GLP-1 ...